Product Description

Fulviglen 250mg Injection contains the active constituent fulvestrant. It is used in the treatment of estrogen receptor-positive metastatic breast cancer in postmenopausal women. It is also used in combination with Palbociclib in the treatment of hormone receptor-positive, and human epidermal growth factor 2-negative breast cancer (metastatic). It is not recommended in patients with chronic liver problems. 

Talk to your doctor if you have bleeding disorders, bone diseases, alcoholism, liver or kidney problems. It is not recommended for adolescents and children under 18 years of age. Use effective birth control during the treatment and for at least 2 years after the last dose.  Inform your doctor if you experience any allergic reactions such as swelling of the face, lips, tongue or throat while being treated with Fulviglen 250mg Injection.

How to use

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Uses

Treatment of Breast cancer

Side Effects

Serious: 

• Sudden signs of allergy (swelling of face, lips, tongue or throat)
• Risk of blood clots
• Liver failure
• Low level of platelets

Common: 

• Nausea, vomiting
• Diarrhea
• Backpain
• Weakness
• Joint and muscle pain
• Loss of appetite
• Feeling of intense heat with sweating
• Injection site reactions (pain, inflammation)
• Headache
• Vaginal bleeding

Storage

Store in a refrigerator (2 - 8)℃